Immunogenicity and safety of a multicomponent meningococcal serogroup B vaccine in healthy adolescents in Korea-A randomised trial

Two doses of 4CMenB induced robust immune responses against the vaccine antigens and were well tolerated, with no safety concerns identified, in Korean adolescents (NCT01973218).